Would Transdermal Low Dose Naltrexone (LDN) Be Good at Controlling Cutaneous Mastocytosis?

1 Views

07/09/23

Would Transdermal Low Dose Naltrexone (LDN) Be Good at Controlling Cutaneous Mastocytosis?

Answered by Nat Jones, R.Ph. FAPC

For information on LDN, go to https://linktr.ee/ldnrt

Our webinar can be purchased https://[a]www.ldnrtevents.com%2Fcollections%2Fwebinars-and-training-courses[/a] and we have a list of LDN Q&As on our website https://ldnresearchtrust.org/questions-and-answers

Checkout our LDN Webinars https://[a]www.ldnrtevents.com%2Fcollections%2Fwebinars-and-training-courses[/a]Check out www.ldnrtevents.com for LDN Webinars, The LDN Book 3, eBooks, Medical Membership etc

Please visit our website https://www.ldnresearchtrust.org which is packed with information on Low Dose Naltrexone (LDN) for Autoimmune Conditions, Cancers, Chronic Pain, Women's Health, Children's Health etc, plus we have a very active FB Closed Group https://www.facebook.com/groups/LDNRT/